1 Curriculum Vitae Maureen P. Hillhouse April, 2021

Hillhouse, M. P.

Curriculum Vitae

Maureen P. Hillhouse April, 2021

EMPLOYMENT CONTACT INFORMATION

New York University 370 Jay Street, Twelfth Floor Brooklyn, NY 11201 [email protected]

PERSONAL CONTACT INFORMATION

6424 Hazel Circle Simi Valley, CA 93063 805-404-3437 [email protected]

EDUCATION

California State University, Northridge B.A., Summa Cum Laude, Psychology, 1991

University of California, Los Angeles M. A., Psychology, 1993

University of California, Los Angeles Ph.D., Psychology, 1998

TEACHING EXPERIENCE

1993, Summer Teaching Assistant; Alcoholism, UCLA.

1993, Fall Teaching Assistant; Fundamentals of Learning, UCLA Taught six discussion sections.

1994, Winter Teaching Assistant; Alcoholism Honors Lab, UCLA

1994, Spring Teaching Assistant; Alcoholism, UCLA

1994, Summer Teaching Associate; Fundamentals of Learning, UCLA Taught three discussion sections.

1994, Fall Teaching Associate; Fundamentals of Learning, UCLA Taught five discussion sections.

1995, Winter Teaching Associate; Research Methods, UCLA

1995, Spring Teaching Associate; Fundamentals of Learning Taught six discussion sections.

1 Hillhouse, M. P.

1995, Fall Teaching Associate; Research Methods, UCLA

1996, Winter-Spring Teaching Associate/Research Coordinator; UCLA Developmental Disabilities Immersion Program (DDIP)

1996, Summer Teaching Associate; Alcoholism, UCLA

PROFESSIONALEXPERIENCE

2016-Present New York University Marron Institute Senior Research Scholar

2015-2016 Pepperdine University School of Public Policy Project Director

2009- 2015 University of California, Los Angeles Neuropsychiatric Institute Integrated Substance Abuse Programs Research Psychologist

1998- 2009 University of California, Los Angeles Neuropsychiatric Institute Integrated Substance Abuse Programs Assistant/Associate Research Psychologist

1993-1997 University of California, Los Angeles Department of Psychology Teaching Associate

1991-1993 University of California, Los Angeles Department of Psychology Research Associate

1990 California State University, Northridge Department of Psychology Research Assistant

OTHER PROFESSIONAL ACTIVITIES

1995-1996 1996 Pacific State Archives, Volume 21

2 Hillhouse, M. P.

Co-Editor

1996-Present Journals: Addiction, Addiction Medicine, Journal of Substance Abuse Treatment Journal Peer Reviewer

2003-present National Institute on Drug Abuse, Entertainment Industries Council; Prism Awards Nomination Review and Prescreening Consultant

2003 The National Association of Drug Court Professionals The National Drug Court Institute Consultant

2003 National Council of Juvenile and Family Court Judges Consultant

2005 Kentucky Judicial Conference Family Court Track: Parental substance abuse and ASFA Consultant

2005 Family Treatment Drug Court Evaluation Coordination Meeting. The Methamphetamine Treatment Project and longitudinal follow-up. Consultant

2009-2015 University of California, Los Angeles South Campus Institutional Review Board Committee Member

HONORS AND AWARDS

1992 University of California, Los Angeles Graduate Division Conference Travel Award

2001 NIDA Travel Award for Junior Investigators College on Problems of Drug Dependence, June

RESEARCH GRANTS/FELLOWSHIPS

1996-1998 National Institute on Drug Abuse Pre-doctoral Fellowship

3 Hillhouse, M. P.

1998-2001 Client Needs and Treatment Effectiveness. National Institute on Drug Abuse (DA11957) Project Director

1998-2002 Client Engagement in Drug Treatment National Institute on Drug Abuse (DA00301) Project Director

1998-2001 The Abuse-Stress Model of Drug Treatment Engagement National Institute on Drug Abuse (DA11047) Project Director

2000-2002 Replicating the Addicted-Self Model of Recovery National Institute on Drug Abuse (DA13619) Principal Investigator

2002-2005 Multi-Year Methamphetamine Treatment Follow-up Study Center for Substance Abuse Treatment (270-01-7089) Project Director

2005-2015 National Institute on Drug Abuse, Clinical Trials Network National Institute on Drug Abuse (DA13045) Investigator

2005-2009 Double-Blind, Placebo-Controlled Trial of Prometa Pharmacotherapy for the Treatment of Methamphetamine Abuse Hythiam (05072347) Investigator

2007-2012 Optimizing Outcomes using Suboxone for Opiate Dependence National Institute on Drug Abuse (DA020210) Co-Investigator

2008-2009 A Randomized, Double-Blind, Cross-Over Trial Comparing the Analgesic Potency and Side Effects of Buprenorphine and Ultra-Low Dose Naloxone to Buprenorphine Alone Reckitt-Benckiser (20080605) Co-Investigator

2009-2013 Sustained-Release Methylphenidate for Management of Methamphetamine Dependence

4 Hillhouse, M. P.

National Institute on Drug Abuse (DA 025084) Co-Investigator

2013-2015 Depot Pharmcotherapies for Opioid-Dependent Offenders: Outcomes and Costs National Institute on Drug Abuse (DA 034743) Co-Investigator

2014-2015 A Randomized, Double Blind, Double Dummy, Active-Controlled Multi- Center Study of Adult Outpatients with Opioid Dependence Transitioned from Buprenorphine to Probuphine Subdermal Implants. Braeburn Pharmaceuticals Co-Investigator

2015-2016 Juveniles under Supervision and Treatment (JUST) Arizona Administrative Office of the Courts Investigator

2015-Current BetaGov Laura and John Arnold Foundation Associate Director

2015-Current Swift, Certain, Fair Training and Technical Assistance Center Bureau of Justice Assistance Investigator

SELECTED PRESENTATIONS:

1. Hillhouse, M. P. (1993). Salivary responses to food presentation in Prader-Willi Syndrome. Paper presented at the 101st meeting o the American Psychology Association, Toronto, August. 2. Hillhouse, M. P., & Maltzman, I. (1994). Medication effects on the salivary response in the developmentally disabled. Poster presented at the Western Psychological Association Annual Meeting, Kona, Hawaii, April. 3. Hillhouse, M. P. (1998). Adolescent substance misuse: The need for an empirically derived typology. Poster presented at the Annual Meeting of the College on Problems of Drug Dependence, Scottsdale, Arizona, June. 4. Hillhouse, M. P., & Fiorentine, R. (1999). Drug treatment outcome: The role of 12-Step ideology. Poster presented at the Annual Meeting of the Western Psychological Association, Irvine, CA, May. 5. Hillhouse, M. P., Grella, C. M., & Anglin, M. D. (1999). Personality characteristics of adolescents in treatment for alcohol and other drug misuse. Paper presented at the scientific meeting of the College on Problems of Drug Dependence, 61st annual meeting, Acapulco, Mexico, June. 6. Fiorentine, R., & Hillhouse, M. P. (1999). Drug treatment and 12-Step program participation: The additive effects of integrated recovery activities. Poster presented at the scientific

5 Hillhouse, M. P.

meeting of the College on Problems of Drug Dependence, 61st annual meeting, Acapulco, Mexico, June. 7. Hillhouse, M. P. (2000). Gender differences of adolescents in substance misuse treatment. Presentation made to the 26th meeting of the California Substance Abuse Research Consortium, Sacramento, April. 8. Hillhouse, M. P., & Fiorentine, R. (2000). Concurrent treatment and 12-Step participation. Poster presented at NIDA conference, Blending Clinical Practice and Research, Los Angeles, November 1-2. 9. Fiorentine, R., & Hillhouse, M. P. (2000). Cognitive Factors in Recovery: The Addicted-Self Model. Poster presented at NIDA conference, Blending Clinical Practice and Research, Los Angeles, November 1-2. 10. Fiorentine, R., & Hillhouse, M. P. (2001). It is low, not high, self-efficacy that correctly specifies the relationship between self-efficacy and the cessation of alcohol and drug dependent behavior. Presented at the 32nd annual conference of the American Society of Addiction Medicine, May. 11. Hillhouse, M. P., & Fiorentine, R. (2001). Concurrent participation in drug treatment and 12- Step programs is associated with better outcomes. Presented at the 32nd annual conference of the American Society of Addiction Medicine, May. 12. Fiorentine, R., & Hillhouse, M. P. (2001). Why low self-efficacy promotes addiction cessation. Presented at the 63rd annual meeting of the College on Problems of Drug Dependence, June. 13. Hillhouse, M. P. & Fiorentine, R. (2001). The effects of gender and ethnicity on 12-Step participation and effectiveness. Presented at the 63rd annual meeting of the College on Problems of Drug Dependence, June. 14. Hillhouse, M. P. & Fiorentine, R. (2001). Why extensive participation in addiction recovery activities promotes abstinence. Poster presented at the American Psychological Association annual meeting, San Francisco, August. 15. Fiorentine, R., & Hillhouse, M. P. (2001). Recovery from addiction: When low self-efficacy is efficacious. Poster presented at the American Psychological Association annual meeting, San Francisco, August. 16. Hillhouse, M.P. (2002). The CSAT methamphetamine Treatment Project: Client change from baseline to treatment end. Presented at the American Psychological Association annual meeting. Chicago, August. 17. Hillhouse, M.P. & Marinelli-Casey, P. (2002). The CSAT Methamphetamine Treatment Project: Client change from baseline to treatment end. Presentation at the Institutional Training Grant Lecture Series, UCLA Integrated Substance Abuse Programs, Los Angeles. (November 15). 18. Hillhouse, M., Marinelli-Casey, P., Reiber, C., & Rawson, R. (2003). The CSAT Methamphetamine Treatment Project: Predictors of Outcome. Poster presented at the 65th annual meeting of the College on Problems of Drug Dependence, Bar Harbor, Florida, June. 19. Willis, R., & Hillhouse, M. (2003). Findings from the Methamphetamine Treatment Project: Weight concerns and depression in females. Poster presented at the 65th annual meeting of the College on Problems of Drug Dependence, Bar Harbor, Florida, June. 20. Hillhouse, M.P. (2003). Substance Abuse. Presented to the National Drug Court Institute and The National Association of Drug Court Professionals, Family Drug Court Skills-Based Training Program. Billings, Montana (July). 21. Hillhouse, M.P. (2003). Intergenerational Issues. Presented to the National Drug Court Institute and The National Association of Drug Court Professionals, Family Drug Court Skills- Based Training Program. Billings, Montana (July).

6 Hillhouse, M. P.

22. Hillhouse, M. P. (2003). Substance use and abuse: Using research to guide practice. Presentation to the National Council of Juvenile and Family Court Judges. Portland, Oregon. (May 29-30). 23. Hillhouse, M.P., & Marinelli-Casey, Patricia. (2003). Researching Methamphetamine Dependence: From the MTP to MAT-SS. Presentation at the Institutional Training Grant Lecture Series, UCLA Integrated Substance Abuse Programs, Los Angeles. (December 12). 24. Hillhouse, M. (2004). Methamphetamine addiction and treatment: Knowledge gained from research. Paper presented at the California Addiction Training and Education Series on Methamphetamine, March 31. 25. Hillhouse, M. (2004) Methamphetamines: Knowledge gained from research. Paper presented at the UCLA School of Nursing and The Center for Vulnerable Populations Research (CVPR) colloquium, Methamphetamine: Health Effects and Treatment Outcomes, May 27. 26. Hillhouse, M. P. (2004). The Multiyear Methamphetamine treatment follow-up: Challenges of a longitudinal design. Presentation at the Institutional Training Grant Lecture Series, UCLA Integrated Substance Abuse Programs, Los Angeles, November 19. 27. Warren, J., Hillhouse, M., & Marinelli-Casey, P. (2005). Poster presented at the annual conference of the Center for HIV Identification, Prevention, and Treatment Services, Los Angeles, California, April. 28. Hillhouse, M., Marinelli-Casey, P., & Rawson, R. (2005). The LET (Life Experience Timeline): A new instrument for collecting time-anchored natural history data. Poster presented at the 67th annual meeting of the College on Problems of Drug Dependence, Orlando, Florida, June. 29. Marinelli-Casey, P., Hillhouse, M., & Rawson, R. (2005). Assessing Psychological disorders among methamphetamine users: The Multiyear Methamphetamine Treatment Follow-Up Study. Poster presented at the 67th annual meeting of the College on Problems of Drug Dependence, Orlando, Florida, June. 30. Ling, W., Torrington, M., Keating, M., Fradis, J., Rathner, J. C., & Hillhouse, M. (2005). Buprenorphine Induction: An Algorithm. Poster presented at the 67th annual meeting of the College on Problems of Drug Dependence, Orlando, Florida, June. 31. Hillhouse, M. P. (2005). Parental substance abuse and ASFA. Presentation to the Kentucky Judicial Conference, Family Court Track. Lexington, Kentucky, June 28. 32. Hillhouse, M. P., & Marinelli-Casey, P. (2006). Nervous system problems in methamphetamine dependent adults. Presented at the 2006 Addiction Society in Medicine annual meeting, May, San Diego. 33. Hillhouse, M. P., & Marinelli-Casey, P. (2006). Hepatitis in methamphetamine-dependent adults. Presented at the 2006 Addiction Society in Medicine annual meeting, May, San Diego. 34. Hillhouse, M. P. & Marinelli-Casey, P. (2006). Acute negative health consequences related to methamphetamine dependence. Presented at the 2006 Addiction Society in Medicine annual meeting, May, San Diego. 35. Thomas, C., Fradis, J., Keating, M., Hillhouse, M., & Ling, W. (2006). Pain responses in opiate-maintained patients. Presented at the 2006 Addiction Society in Medicine annual meeting. 36. Marinelli-Casey, P., Hillhouse, M. P., & Rawson, R. (2006). 12-Step participation of methamphetamine-dependent adults previously participating in the Methamphetamine Treatment Project (MTP). Presented at the annual meeting of the College on Problems of Drug Dependence, June, Scottsdale. 37. Hillhouse, M. P., Marinelli-Casey, M. P, & Rawson, R. (2006). The manufacture and sales of methamphetamine. Presented at the annual meeting of the College on Problems of Drug Dependence, June, Scottsdale.

7 Hillhouse, M. P.

38. Ling, W., Hillhouse, M.P., Domier, C.P., & The Buprenorphine Study Protocol Group. (2006). The role of ancillary meds in treatment with buprenorphine. Presented at the annual meeting of the College on Problems of Drug Dependence, June, Scottsdale. 39. Hillhouse, M., Marinelli-Casey, P., Hunter, J., Cosmineanu-F., Gonzales, R., & Rawson, R. A. (2007). Methamphetamine-dependent treatment participants as parents. Presented at the annual meeting of the College on Problems of Drug Dependence. June, Quebec City. 40. Marinelli-Casey, P., Hillhouse, M., Gonzales, R., Ang, A., Cosmineanu, F., Hunter, J, & Rawson, R. A. (2007). Methamphetamine dependence: Assessing participants in the Methamphetamine Treatment Project 4 years after treatment. Presented at the annual meeting of the College on Problems of Drug Dependence. June, Quebec City. 41. Gonzales, R., Marinelli-Casey, P., Hillhouse, M., Ang, A., Zweben, J., Cohen, J., Fulton Hora, P., Rawson, R. A. (2007). Drug court treatment for methamphetamine dependence: Treatment response and post-treatment outcomes. Presented at the annual meeting of the College on Problems of Drug Dependence. June, Quebec City. 42. Glasner-Edwards, S., Marinelli-Casey, P., Hillhouse, M., Gonzales, R., Ang, A., Cosmineanu, F., & Rawson, R. A. (2007). Psychiatric illness as a predictor of post-treatment methamphetamine use. Presented at the annual meeting of the College on Problems of Drug Dependence. June, Quebec City. 43. Domier, C. P., Hillhouse, M., Doraimani, G., & Ling, W. (2007). Predictors of buprenorphone treatment outcome. Presented at the annual meeting of the College on Problems of Drug Dependence. June, Quebec City. 44. Jenkins, J., Hillhouse, M., & Ling, W. (2007). Can psychosocial treatment increase positive outcomes in buprenorphine-treated opioid-dependent adults? Presented at the annual meeting of the College on Problems of Drug Dependence. June, Quebec City. 45. Ling, W., Hillhouse, M., Domier, C., Thomas, C., Jenkins, J., Doraimani, G., Annon, J, & Hunter, J. (2007). Buprenorphine stabilization: Does dose matter? Presented at the annual meeting of the College on Problems of Drug Dependence. June, Quebec City. 46. Hasson, A., Thomas, C., Jenkins, J., Hillhouse, M., Doraimani, G., & Ling, W. (2007). Buprenorphine retention in the CTN START study: An unexpected observation. Presented at the annual meeting of the College on Problems of Drug Dependence. June, Quebec City. 47. Marinelli-Casey, P., Hillhouse, M., Gonzales, R., & Glasner-Edwards, S. (2007). The Methamphetamine Treatment Project (MTP) and Methamphetamine Abuse Treatment Special Studies (MAT-SS) 3-year follow-up. Presented at the ISAP Scientific Meeting, October 19. 48. Glasner-Edwards, S., Mooney, L.J., Marinelli-Casey, P., Hillhouse, M., Ang, A., & Rawson, R.A. (2007, November). Clinical course of depression in methamphetamine users: association with clinical outcomes 3 years after treatment. Paper presented at the 18th annual meeting of the American Academy of Addiction Psychiatry (San Diego, California). 49. Mooney, L.J., Glasner-Edwards, S., Marinelli-Casey, P., Hillhouse, M., Ang, A., & Rawson, R.A. (2007, November). Predictors of depression and suicide attempts in methamphetamine dependent patients. Paper presented at the 18th Annual Meeting of the American Academy of Addiction Psychiatry (San Diego, CA). 50. Hillhouse, M. (2008). The Methamphetamine Treatment Project (MTP) and Methamphetamine Abuse Treatment Special Studies (MAT-SS) 3-Year Follow-Up. Presented at the ISAP Scientific Meeting, July 22, 2008. 51. Glasner-Edwards, S., Mooney, L.J., Marinelli-Casey, P., Hillhouse, M., Ang, A., & Rawson, R.A. (2008, June). Treatment outcomes of methamphetamine dependent adults with psychotic disorders. Paper presented at the 70th annual meeting of the College on Problems of Drug Dependence (San Juan, Puerto Rico).

8 Hillhouse, M. P.

52. Chen, H., Ling, W., Hillhouse, M., Du, J., & Zhao, M. (2009).Cognitive Behavior Therapy contributes to the self perceptions of heroin addicts in compulsory programs. Presented at the annual meeting of the College on Problems of Drug Dependence. June, Reno, Nevada. 53. Domier, C., Hillhouse, M., Marinelli-Casey, P., & Rawson, R. (2009). Cognitive distinctions between currently using and abstaining methamphetamine-dependent individuals. Presented at the annual meeting of the College on Problems of Drug Dependence. June, Reno, Nevada. 54. Fahey, J., Hillhouse, M., Jenkins, J., Torrington, M., Domier, C., & Ling, W. (2009). Medical care utilization and opiate dependence. Presented at the annual meeting of the College on Problems of Drug Dependence. June, Reno, Nevada. 55. Haynes, L., Walquist, A., Carter, R., Back, S., Hillhouse, M. (2009). Gender differences at presentation for treatment-seeking opiate dependence. Presented at the annual meeting of the College on Problems of Drug Dependence. June, Reno, Nevada. 56. Hillhouse, M., Fahey, J., Jenkins, J., Ling, W., & Rawson, R. (2009). Variation in retention by behavioral condition in buprenorphine treatment for opioid dependence. Presented at the annual meeting of the College on Problems of Drug Dependence. June, Reno, Nevada. 57. Ling, W., Hillhouse, M., Jenkins, J., Miotto, K., Mooney, L., Torrington, M., Reed, S., McGraw, L., & Chim, D. (2009). A clinical trial comparison of two formulations of depot buprenorphine for pain. Presented at the annual meeting of the College on Problems of Drug Dependence. June, Reno, Nevada. 58. Manneh, C., Hillhouse, M., Schroeder, S., & Rawson, R. (2009). HIV Risk Behaviors by Sexual Orientation after Treatment for Methamphetamine Dependence. Presented at the annual meeting of the College on Problems of Drug Dependence. June, Reno, Nevada. 59. Mooney, L., Glasner-Edwards, S., Marinelli-Casey, P., Hillhouse, M., Ang, A., Hunter, J., Haning, W., Colescott, P., Ling, W., & Rawson, R. (2009). Medical outcomes in methamphetamine-dpedent adults three years after treatment. Presented at the annual meeting of the College on Problems of Drug Dependence. June, Reno, Nevada. 60. Schroeder, S., Miotto, K., Hillhouse, M., Manneh, C., Domier, C. P. & Ling, W. (2009). The effect of treatment setting on outcome in treating opioid dependence with buprenorphine. Presented at the annual meeting of the College on Problems of Drug Dependence. June, Reno, Nevada. 61. Cohen, A. J., George, D., Langlois, C., Moreno, A., Yomjinda, D., Boubion, C., Martin, J., Donovick, R., Vimiero, C., Thomas, C., Hasson, A., Hillhouse, M., & Ling, W. (2010). Implementing research in traditional community treatment programs: Findings from a CTN trial. Presented at the annual meeting of the College on Problems of Drug Dependence. June, Scottsdale, Arizona. 62. Thomas, C., Hillhouse, M., Hasson, A. L., & Ling, W. (2010). Hepatitis B and C prevalence in opioid-dependent treatment participants: Comparisons between heroin and prescription opioid users. Presented at the annual meeting of the College on Problems of Drug Dependence. June, Scottsdale, Arizona. 63. Hillhouse, M. P., Fahey, J., & Ling, W. (2010). Drug use attitudes and beliefs and treatment outcome. Presented at the annual meeting of the College on Problems of Drug Dependence. June, Scottsdale, Arizona. 64. Chen, H., Hillhouse, M. P., Hasson, A., & Ling, W. (2010). Craving intensity and withdrawal severity across phases of opioid detoxification with buprenorphine. Presented at the annual meeting of the College on Problems of Drug Dependence. June, Scottsdale, Arizona. 65. Teruya, C., Thomas, C., Hasson, A., Hillhouse, M., Hser, Y, & Ling, W. (2010). Retaining participants in Starting Treatment with Agonist Replacement Therapies: Perspectives of early Suboxone dropouts. Presented at the annual meeting of the College on Problems of Drug Dependence. June, Scottsdale, Arizona.

9 Hillhouse, M. P.

66. Glasner-Edwards, S., Mooney, L. J., Marinelli-Casey, P., Hillhouse, M., Ang, A., & Rawson, R. (2010). Treatmetn outcomes of methamphetamine-dependent adults with anxiety disorders. Presented at the annual meeting of the College on Problems of Drug Dependence. June, Scottsdale, Arizona. 67. Torrington, M., Hillhouse, M. P., & Ling, W. (2010). Treatment with flumazenil: Comparisons of treatment outcomes among patients according to primary drug of abuse. Presented at the annual meeting of the College on Problems of Drug Dependence. June, Scottsdale, Arizona. 68. Fahey, J., Hillhouse, M., Jenkins, J., Rawson, R., & Ling, W. (2010). Comparing heroin users and prescription opioid users seeking Suboxone treatment for opioid dependence. Presented at the annual meeting of the College on Problems of Drug Dependence. June, Scottsdale, Arizona. 69. Ling, W., & Hillhouse, M. (2010). Beliefs and treatment outcome. Presented at the annual meeting of the College on Problems of Drug Dependence. June, Scottsdale, Arizona. 70. Schroeder, S. M., Hillhouse, M., & Ling, W. (2010). Physical, sexual, and emotional abuse in a methamphetamine-dependent treatment follow-up sample. Presented at the annual meeting of the College on Problems of Drug Dependence. June, Scottsdale, Arizona. 71. Ling, W., Hasson, A., & Hillhouse, M. (2010). Differences in retention by buprenorphine treatment site. Presented at the annual meeting of the American Association for the Treatment of Opioid Dependence, October, Chicago, Illinois. 72. Hillhouse, M., Fahey, J., Hasson, A., & Ling, W. (2010). Comparison of psychosocial treatments added to pharmacotherapy with buprenorphine. Presented at the annual meeting of the American Association for the Treatment of Opioid Dependence, October, Chicago, Illinois. 73. Hasson, A., Thomas, C., Hillhouse, M., & Ling, W. (2010). Risk behaviors among patients on pharmacotherapies for opioid dependence. Presented at the annual meeting of the American Public Health Association, November, Denver, Colorado. 74. Nielsen, S., Hillhouse, M., Thomas, C., Hasson, A., & Ling, W. (2011). A comparison of buprenorphine taper outcomes between prescription opioid and heroin users. Presented at the Annual Meeting of the College on Problems of Drug Dependence, June, Hollywood, Florida. 75. Thornton, B., Hillhouse, M., Schroeder, S., & Ling, W. (2011). High-risk HIV behaviors in prescription opioid, IV heroin, and non-IV heroin users. Presented at the Annual Meeting of the College on Problems of Drug Dependence, June, Hollywood, Florida. 76. Bardi, M., Hillhouse, M., & Ling, W. (2011). Pharmacotherapy with buprenorphine and behavioral therapy for reducing other drug use in opioid dependent study participants. Presented at the Annual Meeting of the College on Problems of Drug Dependence, June, Hollywood, Florida. 77. Schroeder, S. M., Hillhouse, M., Thornton, B., & Ling, W. (2011). Medical care utilization in a methamphetamine-dependent treatment follow-up sample. Presented at the Annual Meeting of the College on Problems of Drug Dependence, June, Hollywood, Florida. 78. Hillhouse, M., Fahey, J., Reed, S., Nelson, E., Thornton, B., & Ling, W. (2011). 12-Step participation in opioid-dependent participants receiving buprenorphine and behavioral treatment. Presented at the Annual Meeting of the College on Problems of Drug Dependence, June, Hollywood, Florida. 79. Nielsen, S., Hillhouse, M., Mooney, L., Fahey, J., & Ling, W. (2011). Buprenorphine induction outcomes for heroin and prescription opioid users. Presented at the Annual Meeting of the College on Problems of Drug Dependence, June, Hollywood, Florida. 80. Nelson, E., Hillhouse, M., Smith, M., Reed, S., & Ling, W. (2011). Spiritual and religious beliefs and behaviors, self-help participation and opioid use. Presented at the Annual Meeting of the College on Problems of Drug Dependence, June, Hollywood, Florida.

10 Hillhouse, M. P.

81. Mooney, L., Hillhouse, M., Thomas, C., Hasson, A., & Ling, W. (2011). Variations in outcomes and patient characteristics associated with methadone and buprenorphine dose. Presented at the Annual Meeting of the College on Problems of Drug Dependence, June, Hollywood, Florida. 82. Chen, H., Ling, W., Hillhouse, M., Hasson, A. L., Du, J., & Zhao, M. (2011). Randomized controlled trial of group counseling sessions for the prevention of relapse among heroin addicts in Shanghai. Presented at the Annual Meeting of the College on Problems of Drug Dependence, June, Hollywood, Florida. 83. Glasner-Edwards, S., Mooney, L. J., Marinelli-Casey, P., Hillhouse, M., Ang, A., & Rawson, R. (2011). Association of bulimia nervosa with treatment outcomes of methamphetamine- dependent adults. Presented at the Annual Meeting of the College on Problems of Drug Dependence, June, Hollywood, Florida. 84. Glasner-Edwards, S., Mooney, L. J., Ang, A., Marinelli-Casey, P., Hillhouse, M., & Rawson, R. (2012) Association of post-traumatice stress disorder with post-treatment outcomes of methamphetamine-dependent adults. Oral presentation at the 2012 meeting of the College on Problems of Drug Dependence, June, Palms Springs, California. 85. Hillhouse, M.P., Thomas, C., Jenkins, J., Fahey, J., Thornton, B., Schaper, E., & Ling, W. (2012). Comparison of contingency management reinforcement schedules provided with buprenoprhine for the treatment of opioid dependence. Presented at the 2012 meeting of the College on Problems of Drug Dependence, June, Palms Springs, California. 86. Ling, W., Hillhouse, M. P., Fahey, J., Thornton, B., Schaper, E., Jenkins, J., MacNicoll, S., Reed, S., Mooney, L., Miotto, K., Torrington, M., Dickerson, D. (2012). Behavioral treatment added to pharmacotherapy with buprenorphine for opioid dependence. Presented at the 2012 meeting of the College on Problems of Drug Dependence, June, Palms Springs, California. 87. Nielsen, S., Hillhouse, M., Mooney, L., & Ling, W. (2012). Opioid use and retention outcomes following 18 weeks of buprenorphine for prescription opioid and heroin users. Presented at the 2012 meeting of the College on Problems of Drug Dependence, June, Palm Springs, California. 88. Nielsen, S., Hillhouse, M., Mooney, L., Sharpe-Potter, J., Weiss, R., Lee, J., & Ling, W. (2012). Buprenorphine for prescription opioid users: Findings from the Prescription Opiate Addiction Treatment Study (POATS). Presented at the 2012 meeting of the College on Problems of Drug Dependence, June, Palms Springs, California. 89. Ling, W., Hillhouse, M., Thomas, C., Hasson, A., Annon, J., Mooney, L., Saxon, A., Blumberg, D., Weimer, M., Koosis, E., Brigham, G., Woody, G., Trivedi, M., Drexler, K., Dawes, M. (2013). Cocaine Use Reduction with Buprenorphine (CURB): Study methods and participant baseline characteristics. Presented at the 2013 meeting of the College on Problems of Drug Dependence, June, San Diego, California. 90. Annon, J., Hillhouse, M. P., & Ling, W. (2013). Early drop-out: An indication of treatment success or difficulties? Presented at the 2013 meeting of the College on Problems of Drug Dependence, June, San Diego, California. 91. Hillhouse, M. P., Jenkins, J., MacNicoll, S., Reed, S., Mooney, L., Miotto, K., Torrington, M., Dickerson, D., & Ling, W. (2013). Long-term follow-up of medication treatment with and without a behavioral component for opioid-dependent participants. Presented at the 2013 meeting of the College on Problems of Drug Dependence, June, San Diego, California. 92. Jacobs, P., Ang, A., Hillhouse, M. P., Mooney, L., Saxon, A., Potter, J. S., Nielsen, S., Wakin, P., & Blaine, J. (2013). Treatment outcomes by patterns of methadone and buprenorphine induction strategies: Does higher dose and faster induction improve outcomes? Presented at the 2013 meeting of the College on Problems of Drug Dependence, June, San Diego, California.

11 Hillhouse, M. P.

93. Lindblad, R., McCormack, J., Saxon, A., Hillhouse, M. P., Thomas, C., Hasson, A., Mooney, L., VanVeldhuisen, P., & Ling, W. (2013). Induction onto extended-release naltrexone in 302 cocaine-dependent opioid users. Presented at the 2013 meeting of the College on Problems of Drug Dependence, June, San Diego, California. 94. Mooney, L., Hillhouse, M. P., Ang, A., Miotto, K., Torrington, M., Dickerson, D., MacNicoll, S., Jenkins, J., Reed, S., & Ling, W. (2013). Psychiatric diagnoses and treatment outcomes in opioid-dependent individuals receiving buprenorphine and behavioral treatment. Presented at the 2013 meeting of the College on Problems of Drug Dependence, June, San Diego, California. 95. Potter, J. S., Marino, E. N., Hillhouse, M. P., Nielsen, S., Wiest, K., Canamar, C., Martin, J., Ang, A., Baker, R., Saxon, A., & Ling, W. (2013). Buprenorphine and methadone maintenance treatment outcomes for opioid analgesic, heroin, and combined users: Findings from Starting Treatment with Agonist Replacement Therapies (START). Presented at the 2013 meeting of the College on Problems of Drug Dependence, June, San Diego, California. 96. Woody, G. E., Bruce, D., Korthuis, T., Chatre, S., Hillhouse, M., Jacobs, P., Sorenson, J., Saxon, A., & Ling, W. (2013). Buprenorphine-naloxone vs. methadone: Equal HIV risk reduction in START. Presented at the 2013 meeting of the College on Problems of Drug Dependence, June, San Diego, California. 97. Ling, W., Hillhouse, M. P., Jenkins, J., Hernandez, J., Olaer, M., Reed, S., Mooney, L., Torrington, M., Dickerson, D. (2014). Breaking the Ice: Methamphetamine treatment targets: Sustained-release methylphenidate for the treatment of methamphetamine dependence. Oral presentation at the 2014 meeting of the College on Problems of Drug Dependence, June, San Juan, Puerto Rico. 98. Ling, W., Hillhouse, M. P., Jenkins, J., Hernandez, J., Olaer, M., Reed, S., Mooney, L., Torrington, M., Dickerson, D. (2014). Sustained-release methylphenidate for the treatment of methamphetamine dependence. Presented at the 2014 meeting of the College on Problems of Drug Dependence, June, San Juan, Puerto Rico. 99. Mooney, L., Hillhouse, M.P., Ang, A., Jenkins, J., Ling, W. (2014). Methamphetamine dependence, psychiatric disorders, and treatment outcomes in individuals treated with methylphenidate. Presented at the 2014 meeting of the College on Problems of Drug Dependence, June, San Juan, Puerto Rico. 100. Oyama, M., Hillhouse, M., Thomas, C., Annon, J., Hasson, A., Mooney, L., Walker, R., Chang, L., Sparenborg, S., Ling, W. (2015). Using cellphone technology to monitor and increase dosing adherence. Presented at the 2015 meeting of the College on Problems of Drug Dependence, June. Phoenix, Arizona. 101. Annon, J., Hillhouse, M., Thomas, C., Mooney, L., Hasson, A., Walker, R., Chang, L., Sparenborg, S., Lindblad, R., Van Veldhuisen, Ling, W. (2015). A new study methodology: ADAPT - The short, staged trial. Presented at the 2015 meeting of the College on Problems of Drug Dependence, June. Phoenix, Arizona. 102. Hasson, A., Hillhouse, M., Thomas, C., Mooney, L., Ling, W. (2015). Alcohol and tobacco use in cocaine-dependent participants provided treatment with buprenorphine/nalxone and naltrexone. Presented at the 2015 meeting of the College on Problems of Drug Dependence, June. Phoenix, Arizona. 103. Ling, W., Hillhouse, M., Saxon, A., Mooney, L., Thomas, C., Ang, A., Hasson, A., Annon, J. CURB Study Group. (2015). The Cocaine Use Reduction with Buprenrophine (CURB) Study: Cocaine use outcomes. Presented at the 2015 meeting of the College on Problems of Drug Dependence, June. Phoenix, Arizona. 104. Hillhouse, M., Ang, A., Thomas, C., Nielsen, S., Walker, R., Potter, J., Brigham, G., Stout, S., Weimer, M., Winhusen, T. (2015). Opioid use severity and treatment outcome in cocaine- dependent participants with a history of opioid abuse/dependence. Presented at the 2015 meeting of the College on Problems of Drug Dependence, June. Phoenix, Arizona.

12 Hillhouse, M. P.

105. Mooney, L., Hillhouse, M., Thomas, C., Ang, A., Annon, J., Reed, S., Ling, W. (2015). Psychiatric problems and treatment outcomes in cocaine-dependent adults treated with buprenorphine/naloxone and long-acting naltrexone. Presented at the 2015 meeting of the College on Problems of Drug Dependence, June. Phoenix, Arizona. 106. Thomas, C., Hillhouse, M., Ang, A., Annon, J., Mooney, L., Hasson, A., Ling, W. (2015). Treatment satisfaction in the CTN Cocaine Use Reduction with Buprenorphine (CURB) Study. Presented at the 2015 meeting of the College on Problems of Drug Dependence, June. Phoenix, Arizona. 107. Ang, A., Hillhouse, M., Jenkins, J.., Reed, S., Ling, W. (2015). Methylphenidate for methamphetamine use disorders in participants with and without ADHD. Presented at the 2015 meeting of the College on Problems of Drug Dependence, June. Phoenix, Arizona. 108. Hillhouse, M. (2016). Religiosity, Drug Use, and Crime. Presented at Pepperdine University Communitas Workshop. Malibu, California, February 2. 109. Hawken, A., & Hillhouse, M. (2017). BetaGov. Invited presentation at the Oregon Justice Reinvestment Conference. Salem, Oregon, February, 16. 110. Hawken, A., & Hillhouse, M. (2017). BetaGov. Invited presentation at the American Society of Evidence-Based Policing annual conference. Phoenix, Arizona, May 22. 111. Hillhouse, M., & Smith, K. (2017). BetaGov: Text Message Reminder Trial. Invited presentation at the Monterey County Superior Court Workshop. Monterey, California, June 26. 112. Hillhouse, M. (2017). BetaGov. Invited presentation at the California Probation Research Network Annual Meeting. Irvine, California. October 11. 113. Hillhouse, M. (2017). Research in the Real World: Assistance by BetaGov. Invited presented at the Association of Criminal Justice Network. Irvine, California. October 12. 114. Shmueli-Blumberg, D., Carrizales, F. A., Kazanis, W. H, Hillhouse, M., Matthews, A., & Potter, J.S. (2018). Changes in Quality of Life in cocaine dependent participants provided treatment with buprenorphine+naloxone combined with extended release naltrexone. Presented at the 2018 meeting of the College on Problems of Drug Dependence, June, San Diego. 115. Hillhouse, M. (2018). BetaGov. Invited presentation at the California Association of Counties Results First Conference. Santa Cruz, California. October 17. 116. Hillhouse, M. (2018). BetaGov. Invited presentation at the meeting of the Probation Managers’ Association of California. San Diego. May 8. 117. Hillhouse, M. (2019). Implementing Evidence-Based Policy: BetaGov. Invited presentation at the American Society of Evidence-Based Policing annual conference. Cincinnati, Ohio, May.

BIBLIOGRAPHY

RESEARCH PAPERS: PEER REVIEWED (PUBLISHED)

1. Fiorentine, R., & Hillhouse, M. P. (1999). Drug treatment effectiveness and counselor empathy: Exploring the effects of gender and ethnic congruency. Journal of Drug Issues, 29, 59-74. 2. Fiorentine, R., Pilati, M., & Hillhouse, M. P. (1999). Drug treatment outcomes: Investigating the long-term effects of sexual and physical abuse histories. Journal of Psychoactive Drugs, 31, 363-372. 3. Fiorentine, R., & Hillhouse, M. P. (2000). Drug treatment and twelve-step program participation: The additive effects of integrated recovery activities. Journal of Substance Abuse Treatment, 18, 65-74.

13 Hillhouse, M. P.

4. Fiorentine, R., & Hillhouse, M. P. (2000). Exploring the additive effects of drug treatment and 12-step involvement: Does 12-step ideology matter? Substance Use and Misuse, 35, 367-397. 5. Fiorentine, R., & Hillhouse, M. P. (2000). Self-efficacy, expectancies, and abstinence acceptance: Further evidence for the Addicted-Self Model of cessation of alcohol and drug dependent behavior. The American Journal of Drug and Alcohol Abuse, 26, 497-521. 6. Hillhouse, M. P. & Fiorentine, R. (2001). 12-Step participation and effectiveness: Do gender and ethnic differences exist? Journal of Drug Issues, 31, 767-780. 7. Fiorentine, R., & Hillhouse, M. P. (2001). The Addicted-Self Model of alcohol and drug dependent behavior cessation: A theory of “natural” recovery? Journal of Drug Issues, 31, 495- 424. 8. Fiorentine, R., & Hillhouse, M. P. (2003). Why extensive participation in treatment and 12-Step programs is associated with the cessation of addictive behaviors: An application of the Addicted-Self Model of recovery. Journal of Addictive Diseases, 22, 35-55. 9. Fiorentine, R., & Hillhouse, M. P. (2003). Replicating the Addicted-Self Model of Recovery. Addictive Behaviors, 28, 1068-1080. 10. Fiorentine, R. & Hillhouse, M. P. (2003). When low self-efficacy is efficacious: Toward an Addicted-self Model of Cessation of Alcohol- and Drug-dependent Behavior. American Journal on Addictions, 12, 346-364. 11. Hillhouse, M. P. & Fiorentine, R. (2004). The addicted-self model of addictive behavior cessation: does it predict recovery for gender, ethnic, age, and drug preference subgroups? The American Journal on Addictions, 13, 268-280. 12. Ling, W., Amass, L., Shoptaw, S., Annon, J. J., Hillhouse, M., Babcock, D., Grigham, G., Harrer, J., Reid, M., Muir, J., Buchan, B., Orr, D., Woody, G., Krejci, J., and the Buprenorphine Study Protocol Group. (2005). A multi-center randomized trial of buprenorphine-naloxone versus clonidine for opioid detoxification: Findings from the National Institute on Drug Abuse Clinical Trials Network. Addiction, 100, 1090-1100. PMCID: PMC1480367 13. Torrington, M. A., Domier, C. P., Hillhouse, M. & Ling, W. (2007). Buprenorphine 101: Treating opioid dependence with buprenorphine in an office-based setting. Journal of Addictive Diseases, 26, 93-99. 14. Hillhouse, M. P.; Marinelli-Casey, P.; Gonzales, R.; Ang, A., Rawson, R. A., & the Methamphetamine Treatment Project Corporate Authors. (2007). Predicting in-treatment performance and post-treatment outcomes in methamphetamine users. Addiction,102 (suppl. 1), 84 - 95. 15. Ling, W., Hillhouse, M., Domier, C., Doraimani, G., Hunter, J., Thomas, C., Jenkins, J., Hasson, A., Annon, J., Saxon, A., Selzer, J., Boverman, J., & Bilangi, R., (2007). Buprenorphine tapering schedule and illicit opioid use. Addiction, 104, 256-265. PMCID: PMC3150159 16. Marinelli-Casey, P., Gonzales, R., Hillhouse, M. P., Ang, A., & Rawson, R. A. (2008). The effectiveness of drug court treatment for methamphetamine dependence: Treatment response and post-treatment outcomes. Journal of Substance Abuse Treatment, 34, 242-248. 17. Messina, N., Marinelli-Casey, P., Hillhouse, M. Rawson, R., Hunter, J., & Ang, A. (2008). Childhood adverse events and methamphetamine use among men and women. Journal of Psychoactive Drugs, suppl 5, 399-410. 18. Messina, N., Marinetti-Casey, P., Hillhouse, M., Ang, A., Hunter, J., & Rawson, R. (2008). Childhood adverse events and health outcomes among methamphetamine-dependent men and woman. International Journal of Mental Health and Addiction, 6, 522-536. 19. Glasner-Edwards, S., Mooney, L.J., Marinelli-Casey, P., Hillhouse, M., Ang, A., & Rawson, R. (2008). Clinical course and outcomes of methamphetamine dependent adults with psychosis. Journal of Substance Abuse Treatment, 35, 445-450.

14 Hillhouse, M. P.

20. Glasner-Edwards, S., Mooney, L.J., Marinelli-Casey, P., Hillhouse, M., Ang, A., & Rawson, R. (2008). Identifying methamphetamine users at risk for major depressive disorder: findings from the MTP at 3-year follow-up. American Journal on Addictions, 17, 99-102. 21. Glasner-Edwards, S., Mooney, L.J., Marinelli-Casey, P., Hillhouse, M., Ang, A., & Rawson, R. (2008). Risk factors for suicide attempts in methamphetamine dependent patients. American Journal on Addictions, 17, 24-27. 22. Gonzales, R., Marinelli-Casey, P., Hillhouse, M., Hunter, J., Rawson, R. A., Mooney, L., & Ang, A. (2008). Hepatitis A and B infection among methamphetamine-dependent users. Journal of Substance Abuse Treatment, 35, 351-352. 23. Ling, W., Hillhouse, M., Domier, C., Doraimani, G., Hunter, J., Thomas, C., Jenkins, J., Hasson, A., Annon, J., Saxon, A., Selzer, J., Boverman, J., & Bilangi, R. (2009). Buprenorphine tapering schedule and illicit opioid use. Addiction, 104, 256-265. 24. Glasner-Edwards, S., Marinelli-Casey, P., Gonzales, R., Hillhouse, M., et al. (2009). Depression among methamphetamine users: association with outcomes from the Methamphetamine Treatment Project at 3-year follow-up. Journal of Nervous & Mental Disease, 197, 225-231. PMCID: PMC2749575 25. Mooney, L.J., Glasner-Edwards, S., Marinelli-Casey, P., Hillhouse, M., Ang, A., Hunter, J., Haning, B., Colescott, P, Ling, W., & Rawson, R.A. (2009). Health conditions in methamphetamine-dependent adults 3 years after treatment. J Addiction Med, 3, 155-163. 26. Hillhouse, M., Domier, C. P., Chim, D., & Ling, W. (2010). Provision of ancillary medications during buprenorphine detoxification does not improve treatment outcomes. Journal of Addictive Diseases, 29, 23-29. PMCID: PMC2856108 27. Glasner-Edwards, S., Mooney, L., J., Marinelli-Casey, P., Hillhouse, M., Ang, A.,, Rawson, R. (2010). Anxiety disorders among methamphetamine dependent adults: Association with post- treatment functioning. The American Journal on Addictions, 19, 385-390. PMCID: PMC3159418 28. Ling, W., Jacobs, P., Hillhouse, M., Hasson, A., Thomas, C., Freese, T., Sparenborg, S., McCarthy, D., Tai, B., Weiss, R., Saxon, A., Cohen, A., Straus, M., Brigham, G., Liu, D., McLaughlin, P. (2010). From research to the real world: Buprenorphine in the decade of the CTN. Journal of Substance abuse Treatment, 38 (Supple 1), S53-61. PMCID: PMC2853172 29. Potter, J. S., Chakrabarti, A., Domier, C.P., Hillhouse, M., Weiss, R., & Ling, W. (2010). Pain and continued opioid use in individuals receiving buprenorphine-naloxone for opioid detoxification: Secondary analyses from the Clinical Trials Network. Journal of Substance Abuse Treatment, 38 (Suppl 1), S80-86. PMCID: PMC3150507 30. Brown, E. S., Tirado, C., Minhajuddin, A., Hillhouse, M., Adinoff, B., Ling, W., Doraimani, G., & Thomas, C. (2010). Association of race and ethnicity with withdrawal symptoms, attrition, opioid use, and side-effects during buprenorphine therapy. Journal of Ethnicity in Substance Abuse, 9, 106-114. PMCID: PMC3176716 31. Glasner-Edwards, S., Mooney, L. J., Marinelli-Casey, P., Hillhouse, M., Ang., A., & Rawson, R. A. (2010). Psychopathology in methamphetamine-dependent adults 3 years after treatment. Drug Alcohol Rev, 29, 12-20. PMCID: PMC3772133 32. Glasner-Edwards, S., Mooney, L. J., Marinelli-Casey, P., Hillhouse, M., Ang., A., & Rawson, R. A. (2011). Bulimia nervosa among methamphetamine dependent adults: Association with outcomes three years after treatment. Eating Disorders, 19, 259-269. PMCID: PMC3159413 33. Ling, W., Mooney, L., & Hillhouse, M. (2011). Prescription opioid abuse, pain, and addiction: Clinical issues and implications. Drug and Alcohol Review, 30, 300-305. PMCID: PMC4170948 34. Hillhouse M, Canamar CP, Doraimani G, Thomas C, Hasson A, Ling W. (2011). Participant characteristics and buprenorphine dose. Am J Drug Alcohol Abuse, 37, 453-459. PMCID: PMC3272773 35. Back SE, Payne RL, Wahlquist AH, Carter RE, Stroud Z, Haynes L, Hillhouse M, Brady KT, Ling W. (2011). Comparative profiles of men and women with opioid dependence: results from

15 Hillhouse, M. P.

a national multisite effectiveness trial. Am J Drug Alcohol Abuse, 37, 313-323. PMCID: PMC3164783 36. Ling, W., Shoptaw, S., Hillhouse, M., Bholat, M. A., Charuvastra, C., Heinzerling, K., Chim, D., Annon, J., Dowling, P. T., & Doraimani, G. (2012). Double-blind placebo-controlled evaluation of the Prometa protocol for methamphetamine dependence. Addiction, 107, 361-369. PMCID: PMC4122522 37. Miotto, K., Hillhouse, M., Donovik, R., Cunningham-Rathner, J., Charuvastra, C., & Ling, W. (2012). Comparison of Buprenorphine Treatment for Opioid Dependence in Three Settings. Journal of Addiction Medicine, 6, 68-76. PMCID: PMC3276753 38. Ling, W., Hillhouse, M., Jenkins, J., Miotto, K., Torrington, M., & Chapleo, C. (2012). Comparisons of analgesic potency and Side Effects of Buprenorphine and Buprenorphine With Ultra-low-dose Naloxone. Journal of Addiction Medicine, 6, 118 - 123. PMID: 22475985 39. Compton, P., Canamar, C. P., Hillhouse, M., & Ling, W. (2012). Hyperalgesia in heroin dependent patients and the effects of opioid substitution therapy. Journal of Pain, 13, 401- 409. Epub 2012 Mar 15. PMCID: PMC33344366 40. Nielsen, S., Hillhouse, M., Mooney, L., Fahey, J., & Ling, W. (2012). Comparing buprenorphine induction experience with heroin and prescription opioid users. J Subst Abuse Treat, 43, 285- 290. PMCID: PMC3350757. 41. Hillhouse, M., Canamar, C. P., & Ling, W. (2013). Predictors of outcome after short-term detoxification with buprenorphine. Journal of Substance Abuse Treatment, 44, 336-342. PMCID: PMC3545105 42. Saxon, A., Ling, W., Hillhouse, M., Thomas, C., Hasson, A., Doraimani, G., Tasissa, G., Lokhnygina, Y., Leimberger, J., Bruce, D., McCarthy, J., Wiest, K., McLaughlin, P., Bilangi, R., Woody, G., & Jacobs, P. (2013). Buprenorphine/Naloxone and methadone effects on liver health: a randomized trial. Drug and Alcohol Dependence, 128, 71-76. PMCID: PMC3543467 43. Nielsen, S., Hillhouse, M., Thomas, C., Hasson, A., & Ling, W. (2013). A comparison of buprenorphine taper outcomes between prescription opioid and heroin users. Journal of Addiction Medicine, 7, 33-38. PMCID: PMC3567310 44. Glasner-Edwards, S., Mooney, L. J., Ang, A., Hillhouse, M, & Rawson, R. (2013) Does posttraumatic stress disorder (PTSD) affect post-treatment methamphetamine use? Journal of Dual Diagnosis, 9, 123-128. PMCID: PMC3779468. 45. Crist, R. C., Clarke, T.K., Ang, A., Ambrose-Lanci, L. M., Lohoff, F. W., Saxon, A. J., Ling, W., Hillhouse, M. P., Bruce, D. R.., Woody, G., & Berrettini, W. H. (2013). An intronic variant in OPRD1 predicts treatment outcome for opioid dependence in African-Americans. Neuropsychopharmacology, 23, 2003-2010. PMCID: PMC3746708 46. Hser, Y.I., Saxon,A. J., Huang, D., Hasson, A., Thomas, C., Hillhouse, M., Jacobs, P., Teruya, C., McLaughlin, P., Wiest, K., Cohen, A., & Ling, W. (2014). Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial. Addiction,109, 79-87. PMCID: PMC3947022 47. Potter, J.S., Marino, E. N., Hillhouse, M. P., Nielsen, S., Wiest, K., Canamar, C. P., Martin, J. A., Ang, A., Baker, R., Saxon, A. J., & Ling, W. (2013) Buprenorphine and methadone maintenance treatment outcomes for opioid analgesic, heroin, and combined users: Findings from Starting Treatment with Agonist Replacement Therapies (START). Journal of Studies on Alcohol and Drug, 74, 605-613. PMCID: PMC3711351 48. Ling, W., Hillhouse, M., Ang, A., Jenkins, J., & Fahey, J. (2013). Comparison of behavioral treatment conditions in buprenorphine maintenance. Addiction, 108, 1788-1798. PMCID: PMC3866908 49. Mooney, L. J., Nielsen, S., Saxon, A., Hillhouse, M., Thomas, C., Hasson, A., Stablein, D., McCormack, J., Lindblad, R., & Ling, W. (2013). Cocaine use reduction with buprenorphine (CURB): rationale, design, and methodology. Contemp Clin Trials, 34, 196-204. PMCID: PMC3760415

16 Hillhouse, M. P.

50. Nielsen, S., Hillhouse, M., Weiss, R. D., Mooney, L., Sharpe-Potter, J., Lee, J., Gourevitch, M. N., & Ling, W. (2014). The relationship between primary prescription opioid and buprenorphine- naloxone induction outcomes in a prescription opioid dependent sample. Am J Addict, 23, 343- 348. PMCID: PMC4151625 51. Clarke, T.K., Crist, R. C., Ang, A., Ambrose-Lanci, L. M., Lohoff, F. W., Saxon, A. J., Ling, W., Hillhouse, M. P. Bruce, R. D., Woody, G., Berrettini, W. H. (2014). Genetic variation in OPRD1 predicts response to buprenorphine treatment for opioid dependence in European American females. Pharmacogenomics J, 14, 303-8. PMCID: PMC3988270 52. Woody, G., Bruce, D., Korthuis, P. T., Chhatre, S., Poole, S., Hillhouse, M., Jacobs, P., Sorenson, J., Saxon, A. J., Metzger, D., & Ling, W. (2014). Equal HIV risk reduction with buprenorphine-naloxone or methadone. J Acquir Immune Defic Syndr, 66, 288-293. PMCID: PMC4146664 53. Ling, W., Chang, L., Hillhouse, M., Ang, A., Striebel, J., Jenkins, J., Hernandez, J., Olaer, M., Mooney, L., Reed, S., Fukaya, E., Kogachi, S., Alicata, D., Holmes, N., & Esagoff, A. (2014). Sustained-release methylphenidate in a randomized trial of treatment of methamphetamine use disorder. Addiction, 109, 1489-500. PMCID: PMC4127124 54. Nielsen, S., Hillhouse, M., Mooney, L., Ang, A., & Ling, W. (2015). Buprenorphine pharmacotherapy and behavioral treatment: Comparison of outcomes among prescription opioid users, heroin users and combination users. J Subst Abuse Treat, 48, 70-76. PMCID: PMC4250309 55. Schulte, M., Hser, Y., Saxon, A., Evans, E., Li, L., Huang, D., Hillhouse, M., Thomas, C., & Ling, W. (2015). Risk Factors Associated with HCV Among Opioid-Dependent Patients in a Multisite Study. J Community Health. 2015 Mar 27. [Epub ahead of print] PMID: 25814381 56. Ling, W., Hillhouse, M. P., Saxon, A. J., Mooney, L. J., Thomas, C. M., Ang, A. et al. (2016). Buprenorphine + naloxone plus naltrexone for the treatment of cocaine dependence: The Cocaine Use Reduction with Buprenorphine (CURB) study. Addiction, 111, 1416-1427. 57. Jiang, H., Hillhouse, M., Du, J., Pan, S., Ang, A., Wang, J., et al. (2016). Dose, plasma level, and treatment outcome among methadone patients in Shanghai, China. Neuroscience Bulletin, 32, 538-544. 58. Farabee, D., Hillhouse, M., Condon, T., McCrady, B., McCollister, K., Ling, W. (2016). Injectable Pharmacotherapy for Opioid Use Disorders (IPOD). Contemporary Clinical Trials, 49, 70-77. 59. Mooney, L. J., Hillhouse, M. P., Thomas, C., Ang, A., Sharma, G., Terry, G., Chang, L., Walker, R., Trivedi, M., Croteau, D., Sparenborg, S., & Ling, W. (2017). Utilizing a two-stage design to investigate the safety and potential efficacy of monthly naltrexone plus once-daily bupropion as a treatment for methamphetamine use disorder. Journal of Addiction Medicine, 10, 236-243. 60. Chandler, R. K., Finger, M.S., Farabee, D., Schwartz, R. P., Condon, T., Dunlap, L. J., Zarkin, G. A., McCollister, K., McDonald, R. D., Laska, E., Bennett, D., Kelly, S. M., Hillhouse, M., Mitchell, S. G., O’Grady, K. E., & Lee, J. D. (2017). The SOMATICS collaborative: Introduction to a National Institute o Drug Abuse cooperative study of pharmacoltherapy for opioid treatment in criminal justice settings. Contemporary Clinical Trials, 48, 166-172. 61. Jacobs, P., Ang, A., Hillhouse, M. P., Saxon, A. J., Nielsen, S., Wakim, P. G., Mai, B. E., Mooney, L. J., Potter, J. S., Blaine, J. D. (2017). Treatment Outcomes in Opioid Dependent Patients With Different Buprenorphine/Naloxone Induction Dosing Patterns and Trajectories. American Journal on Addictions, 24, 667-675. 62. Walker, R., Hillhouse, M., Perrochet, B., Sparenborg, S., Mooney, L., & Ling, W. (2019). Medication adherence monitoring using smartphone video dosing in an open-label pilot study of monthly naltrexone plus once-daily bupropion for methamphetamine use disorder: Feasibility and acceptability. Journal of Addiction Medicine.

17 Hillhouse, M. P.

63. Hillhouse, M., Farabee, D., Smith, K., Nerurkar, J., Sahd, D., Bucklen, K. B., & Hawken, A. (2021). Mindfulness training for correctional staff: A randomized pilot study. Corrections, 1-15. https://doi.org/10.1080/23774657.2021.1900756

RESEARCH PAPERS: NON-PEER REVIEWED (PUBLISHED)

1 Fiorentine, R., Gil-Rivas, V., & Hillhouse, M. P. (1997). Enhancing drug treatment: Evaluation of the Los Angeles Target Cities Project, years 4-5. Report presented to the Center for Substance Abuse Treatment. 2. Fiorentine, R., Nakashima, J., & Hillhouse, M. P. (1998). Evaluation of the Target Cities Earthquake Needs Assessment and Program Modification Grant. Report presented to the Center for Substance Abuse Treatment. 3. Fiorentine, R., & Hillhouse, M. P. (1998). An evaluation of the screening, placement, and assessment instruments used by California Alcohol and Drug Services Providers. Report submitted to the California Department of Alcohol and Drug Programs, System of Care Redesign. 4. Hillhouse, M. P. (1998). Musings of a Pre-doc. FIDAR Newsletter. Spring. 5. Hillhouse, M. P., & Fiorentine, R. (1998). Adolescent delinquency, drug misuse, and drug treatment. Paper presented to the California Youth Authority. 6. Fiorentine, R., & Hillhouse, M. P. (1999). ICMP: Evaluation of the Intensive Case Management Project. Report presented to the Los Angeles County Probation Department. 7. Hawken, A, Farabee, D., Hillhouse, M., Kulick, J., Smith, K., & Lovinger, K. (2015). Evaluation of Juveniles under Supervision and Treatment (JUST). Presented to the Arizona Administrative Office of the Courts.

CHAPTERS (PUBLISHED)

1. Fiorentine, R., Hillhouse, M. P., & Anglin, M. D. (2001). Drug use careers and treatment outcome. In C. Leukefeld, F. Tims, & D. Farabee (eds.), Clinical and policy responses to drug offenders (pp. 273-282). New York, Springer. 2. Rawson, R., Sodano, R., & Hillhouse, M. (2004). Assessment of amphetamine use disorders. In D. Donovan & G. A. Marlatt (Eds.), pp. 185-214, Assessment of addictive disorders. New York: The Guilford Press.

LETTERS TO THE EDITOR

1. Ling, W., Hillhouse, M., Domier, C., Doraimani, G., Hunter, J., Thomas, C., Jenkins, J., Hasson, A., Annon, J., Saxon, A., Selzer, J., Boverman, J., Bilangi, R. (2009). Long suffering or prolonged suffering? Time matters. Addiction, 104, 1429-1430. 2. Woody, G., Bruce, D., Korthuis, P. T., Chhatre, S., Hillhouse, M., Jacobs, P., Sorenson, J., Saxon, A. J., Poole, S., Metzger, D., & Ling, W. (2014). Authors’ Reply: Risk reduction with buprenorphine-naloxone and methadone: Patient’s choice. Journal of Acquired Immune Deficiency Syndromes, 67, 142-143. PMCID: PMC4229390

PUBLISHED ABSTRACTS

1. Hillhouse, M. P., Grella, C. P., & Anglin, M. D. (2000). Personality characteristics of adolescents in treatment for alcohol and other drug misuse: Gender and ethnic differences.

18 Hillhouse, M. P.

NIDA Research Monograph 180, 81. Bethesda, MA: U.S. Department of Health and Human Services. 2. Fiorentine, R., & Hillhouse, M. P. (2000). Drug treatment and Twelve-Step program participation: The additive effects of integrated recovery activities. NIDA Research Monograph 180, 147. Bethesda, MA: U.S. Department of Health and Human Services. 3. Fiorentine, R., & Hillhouse, M. P. (2001). Why low self-efficacy promotes addiction cessation. NIDA Research Monograph 182. Bethesda, MA: U.S. Department of Health and Human Services. 4. Hillhouse, M. P. & Fiorentine, R. (2001). The effects of gender and ethnicity on 12-Step participation and effectiveness. NIDA Research Monograph 182. Bethesda, MA: U.S. Department of Health and Human Services. 5. Hillhouse, M., Marinelli-Casey, P., Reiber, C., & Rawson, R. (2003). The CSAT Methamphetamine Treatment Project: Predictors of Outcome. NIDA Research Monograph 184. Bethesda, MA: U.S. Department of Health and Human Services. 6. Willis, R., & Hillhouse, M. (2003). Findings from the Methamphetamine Treatment Project: Weight concerns and depression in females. NIDA Research Monograph 184. Bethesda, MA: U.S. Department of Health and Human Services. 7. Hillhouse, M., Marinelli-Casey, P., & Rawson, R. (2005). The LET (Life Experience Timeline): A new instrument for collecting time-anchored natural history data. NIDA Research Monograph 186. Bethesda, MA: U.S. Department of Health and Human Services. 8. Marinelli-Casey, P., Hillhouse, M., & Rawson, R. (2005). Assessing Psychological disorders among methamphetamine users: The Multiyear Methamphetamine Treatment Follow-Up Study. NIDA Research Monograph 186. Bethesda, MA: U.S. Department of Health and Human Services. 9. Ling, W., Torrington, M., Keating, M., Fradis, J., Rathner, J. C., & Hillhouse, M. (2005). Buprenorphine Induction: An Algorithm. NIDA Research Monograph 186. Bethesda, MA: U.S. Department of Health and Human Services. 10. Marinelli-Casey, P., Hillhouse, M. P., & Rawson, R. (2006). 12-Step participation of methamphetamine-dependent adults previously participating in the Methamphetamine Treatment Project (MTP). NIDA Research Monograph 187. Bethesda, MA: U.S. Department of Health and Human Services. 11. Hillhouse, M. P., Marinelli-Casey, M. P, & Rawson, R. (2006). The manufacture and sales of methamphetamine. NIDA Research Monograph 187. Bethesda, MA: U.S. Department of Health and Human Services. 12. Ling, W., Hillhouse, M.P., Domier, C.P., & The Buprenorphine Study Protocol Group. (2006). The role of ancillary meds in treatment with buprenorphine. NIDA Research Monograph 187. Bethesda, MA: U.S. Department of Health and Human Services. 13. Hillhouse, M., Marinelli-Casey, P., Hunter, J., Cosmineanu-F., Gonzales, R., & Rawson, R. A. (2007). Methamphetamine-dependent treatment participants as parents. NIDA Research Monograph 188. Bethesda, MA: U.S. Department of Health and Human Services. 14. Marinelli-Casey, P., Hillhouse, M., Gonzales, R., Ang, A., Cosmineanu, F., Hunter, J, & Rawson, R. A. (2007). Methamphetamine dependence: Assessing participants in the Methamphetamine Treatment Project 4 years after treatment. NIDA Research Monograph 188. Bethesda, MA: U.S. Department of Health and Human Services. 15. Gonzales, R., Marinelli-Casey, P., Hillhouse, M., Ang, A., Zweben, J., Cohen, J., Fulton Hora, P., Rawson, R. A. (2007). Drug court treatment for methamphetamine dependence: Treatment response and post-treatment outcomes. NIDA Research Monograph 188. Bethesda, MA: U.S. Department of Health and Human Services. 16. Glasner-Edwards, S., Marinelli-Casey, P., Hillhouse, M., Gonzales, R., Ang, A., Cosmineanu, F., & Rawson, R. A. (2007). Psychiatric illness as a predictor of post-treatment

19 Hillhouse, M. P.

methamphetamine use. NIDA Research Monograph 188. Bethesda, MA: U.S. Department of Health and Human Services. 17. Domier, C. P., Hillhouse, M., Doraimani, G., & Ling, W. (2007). Predictors of buprenorphone treatment outcome. NIDA Research Monograph 188. Bethesda, MA: U.S. Department of Health and Human Services. 18. Jenkins, J., Hillhouse, M., & Ling, W. (2007). Can psychosocial treatment increase positive outcomes in buprenorphine-treated opioid-dependent adults? NIDA Research Monograph 188. Bethesda, MA: U.S. Department of Health and Human Services. 19. Ling, W., Hillhouse, M., Domier, C., Thomas, C., Jenkins, J., Doraimani, G., Annon, J, & Hunter, J. (2007). Buprenorphine stabilization: Does dose matter? NIDA Research Monograph 188. Bethesda, MA: U.S. Department of Health and Human Services. 20. Hasson, A., Thomas, C., Jenkins, J., Hillhouse, M., Doraimani, G., & Ling, W. (2007). Buprenorphine retention in the CTN START study: An unexpected observation. NIDA Research Monograph 188. Bethesda, MA: U.S. Department of Health and Human Services.